{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T20:21:08Z","timestamp":1791231668351,"version":"4.1.0"},"reference-count":138,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,2,3]],"date-time":"2025-02-03T00:00:00Z","timestamp":1738540800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Sanbo Brain Hospital Management Group","award":["SBJT-KY-2020-002"],"award-info":[{"award-number":["SBJT-KY-2020-002"]}]},{"name":"Health Improvement and Research","award":["2022-2-8013"],"award-info":[{"award-number":["2022-2-8013"]}]},{"DOI":"10.13039\/501100012166","name":"National Key R&D Program of China","doi-asserted-by":"publisher","award":["2023YFC2411603"],"award-info":[{"award-number":["2023YFC2411603"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,6,21]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Adamantinomatous craniopharyngioma (ACP) is the most common benign tumor in the sellar region of children and originates from embryonic remnants. Owing to its unique location and frequent tight adhesion to and invasion of surrounding structures, the ACP poses significant challenges for neurosurgical treatment. Traditionally, the core treatment for ACPs has been surgical resection supplemented with radiotherapy in cases of residual or recurrent tumors. As a result, ACP classification has been based primarily on the tumor\u2019s relationship with surrounding anatomical and histological structures, guiding the selection of surgical approaches and the prevention of complications. Moreover, efforts to explore pharmacological treatments for ACP have yielded varying results across different cases, creating confusion among researchers. This variability also suggests the possibility of different molecular subtypes within ACPs, despite being driven by a single-gene mutation. With advancements in molecular biological studies, such as ACP RNA sequencing, whole-exome sequencing, and methylation analysis, along with the discovery of interactions between different molecular pathways within ACP, researchers have been continuously exploring the molecular subtyping of ACP and predicting the efficacy of targeted therapies on the basis of these subtypes. This review focuses on summarizing and synthesizing the molecular mechanisms and potential subtypes of ACP, aiming to provide theoretical support for future research on the molecular subtyping of ACP.<\/jats:p>","DOI":"10.1093\/neuonc\/noaf030","type":"journal-article","created":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T15:26:26Z","timestamp":1738337186000},"page":"1180-1192","source":"Crossref","is-referenced-by-count":12,"title":["Molecular subtypes of adamantinomatous craniopharyngiomas"],"prefix":"10.1093","volume":"27","author":[{"given":"Wenhao","family":"An","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shouwei","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yihua","family":"An","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixiong","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Sanbo Brain Hospital, Capital Medical University , Beijing ,","place":["China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,2,3]]},"reference":[{"key":"2025062423032286600_CIT0001","doi-asserted-by":"crossref","first-page":"106651","DOI":"10.1016\/j.cmpb.2022.106651","article-title":"A multi-task two-path deep learning system for predicting the invasiveness of craniopharyngioma","volume":"216","author":"Zhu","year":"2022","journal-title":"Comput Methods Programs Biomed."},{"issue":"3","key":"2025062423032286600_CIT0002","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1210\/endrev\/bnac035","article-title":"Contemporary biological insights and clinical management of craniopharyngioma","volume":"44","author":"Apps","year":"2023","journal-title":"Endocr Rev."},{"issue":"1","key":"2025062423032286600_CIT0003","doi-asserted-by":"crossref","first-page":"E6","DOI":"10.3171\/2016.2.FOCUS1592","article-title":"Harvey cushing and pituitary case number 3 (Mary D.): the origin of this most baffling problem in neurosurgery","volume":"41","author":"Pascual","year":"2016","journal-title":"Neurosurg Focus."},{"issue":"1","key":"2025062423032286600_CIT0004","doi-asserted-by":"crossref","first-page":"21206","DOI":"10.1038\/s41598-021-00483-4","article-title":"In-depth proteomic profiling captures subtype-specific features of craniopharyngiomas","volume":"11","author":"Kim","year":"2021","journal-title":"Sci Rep."},{"issue":"8","key":"2025062423032286600_CIT0005","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1093\/neuonc\/noab106","article-title":"The 2021 WHO classification of tumors of the central nervous system: a summary","volume":"23","author":"Louis","year":"2021","journal-title":"Neuro Oncol"},{"issue":"3","key":"2025062423032286600_CIT0006","doi-asserted-by":"crossref","first-page":"515","DOI":"10.3390\/brainsci13030515","article-title":"Current advances in papillary craniopharyngioma: state-of-the-art therapies and overview of the literature","volume":"13","author":"Jannelli","year":"2023","journal-title":"Brain Sci"},{"issue":"1","key":"2025062423032286600_CIT0007","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11060-021-03906-4","article-title":"Update on management of craniopharyngiomas","volume":"156","author":"Henderson","year":"2022","journal-title":"J Neurooncol."},{"key":"2025062423032286600_CIT0008","doi-asserted-by":"crossref","first-page":"199","DOI":"10.25259\/SNI_186_2024","article-title":"Quality of life of pediatric patients with craniopharyngioma: a retrospective series from a low-middle-income country with more than 4 years follow-up","volume":"15","author":"Baqai","year":"2024","journal-title":"Surg Neurol Int"},{"issue":"5","key":"2025062423032286600_CIT0009","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3171\/2022.12.PEDS22367","article-title":"Comparison of neurocognitive and quality-of-life outcomes in pediatric craniopharyngioma patients treated with partial resection and radiotherapy versus gross-total resection only","volume":"31","author":"Aldave","year":"2023","journal-title":"J Neurosurg Pediatr"},{"key":"2025062423032286600_CIT0010","doi-asserted-by":"crossref","first-page":"1326595","DOI":"10.3389\/fonc.2023.1326595","article-title":"Advances in the treatment of adamantinomatous craniopharyngioma: how to balance tumor control and quality of life in the current environment: a narrative review","volume":"13","author":"Chen","year":"2023","journal-title":"Front Oncol."},{"issue":"5","key":"2025062423032286600_CIT0011","doi-asserted-by":"crossref","first-page":"569","DOI":"10.3171\/2023.5.PEDS22568","article-title":"Does subtotal resection ameliorate hypothalamic morbidity in pediatric craniopharyngioma? A 30-year retrospective cohort study","volume":"32","author":"Yousuf","year":"2023","journal-title":"J Neurosurg Pediatr"},{"issue":"3","key":"2025062423032286600_CIT0012","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1227\/NEU.0000000000000380","article-title":"Malignant transformation in craniopharyngiomas","volume":"75","author":"Sofela","year":"2014","journal-title":"Neurosurgery."},{"issue":"1","key":"2025062423032286600_CIT0013","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1007\/s00701-024-06113-y","article-title":"Long-term outcomes of neuroendoscopic cyst partial resection combined with stereotactic radiotherapy for craniopharyngioma","volume":"166","author":"Fukuhara","year":"2024","journal-title":"Acta Neurochir (Wien)."},{"issue":"11","key":"2025062423032286600_CIT0014","doi-asserted-by":"crossref","first-page":"2745","DOI":"10.3390\/diagnostics12112745","article-title":"Multidisciplinary management of craniopharyngiomas in children: a single center experience","volume":"12","author":"Del Baldo","year":"2022","journal-title":"Diagnostics"},{"issue":"2","key":"2025062423032286600_CIT0015","doi-asserted-by":"crossref","first-page":"519","DOI":"10.3390\/jcm9020519","article-title":"The inflammatory milieu of adamantinomatous craniopharyngioma and its implications for treatment","volume":"9","author":"Whelan","year":"2020","journal-title":"J Clin Med"},{"issue":"4","key":"2025062423032286600_CIT0016","doi-asserted-by":"crossref","first-page":"136","DOI":"10.31083\/j.fbl2704136","article-title":"Targeted therapy in the management of modern craniopharyngiomas","volume":"27","author":"Reyes","year":"2022","journal-title":"Front Biosci"},{"issue":"6","key":"2025062423032286600_CIT0017","doi-asserted-by":"crossref","first-page":"E4","DOI":"10.3171\/2016.8.FOCUS16307","article-title":"Molecular pathology of adamantinomatous craniopharyngioma: review and opportunities for practice","volume":"41","author":"Apps","year":"2016","journal-title":"Neurosurg Focus."},{"issue":"6","key":"2025062423032286600_CIT0018","doi-asserted-by":"crossref","first-page":"E12","DOI":"10.3171\/2018.3.FOCUS1861","article-title":"Craniopharyngioma: a roadmap for scientific translation","volume":"44","author":"Gupta","year":"2018","journal-title":"Neurosurg Focus."},{"issue":"2","key":"2025062423032286600_CIT0019","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1007\/s11864-023-01156-2","article-title":"Integrating systemic therapies into the multimodality therapy of patients with craniopharyngioma","volume":"25","author":"Gritsch","year":"2024","journal-title":"Curr Treat Options Oncol."},{"issue":"7","key":"2025062423032286600_CIT0020","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1097\/CM9.0000000000002774","article-title":"Multi-omics analysis of adamantinomatous craniopharyngiomas reveals distinct molecular subgroups with prognostic and treatment response significance","volume":"137","author":"Wang","year":"2024","journal-title":"Chin Med J (Engl)."},{"issue":"9","key":"2025062423032286600_CIT0021","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1093\/jnen\/nlaa087","article-title":"Membrane structures between craniopharyngioma and the third ventricle floor based on the QST classification and its significance: a pathological study","volume":"79","author":"Qi","year":"2020","journal-title":"J Neuropathol Exp Neurol."},{"issue":"1","key":"2025062423032286600_CIT0022","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","volume":"5","author":"M\u00fcller","year":"2019","journal-title":"Nat Rev Dis Primers"},{"issue":"9-10","key":"2025062423032286600_CIT0023","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1159\/000506904","article-title":"Biological behaviour of craniopharyngiomas","volume":"110","author":"Martinez-Barbera","year":"2020","journal-title":"Neuroendocrinology."},{"issue":"8","key":"2025062423032286600_CIT0024","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/neuonc\/nos142","article-title":"Incidence, treatment and survival of patients with craniopharyngioma in the surveillance, epidemiology and end results program","volume":"14","author":"Zacharia","year":"2012","journal-title":"Neuro Oncol"},{"issue":"5","key":"2025062423032286600_CIT0025","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nrendo.2016.217","article-title":"New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma","volume":"13","author":"M\u00fcller","year":"2017","journal-title":"Nat Rev Endocrinol."},{"issue":"2","key":"2025062423032286600_CIT0026","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/0002-9394(86)90152-2","article-title":"Magnetic resonance imaging of craniopharyngioma","volume":"102","author":"Johnson","year":"1986","journal-title":"Am J Ophthalmol."},{"issue":"5","key":"2025062423032286600_CIT0027","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00401-018-1830-2","article-title":"Tumour compartment transcriptomics demonstrates the activation of inflammatory and odontogenic programmes in human adamantinomatous craniopharyngioma and identifies the MAPK\/ERK pathway as a novel therapeutic target","volume":"135","author":"Apps","year":"2018","journal-title":"Acta Neuropathol."},{"issue":"10","key":"2025062423032286600_CIT0028","doi-asserted-by":"crossref","first-page":"4521","DOI":"10.1007\/s00018-021-03798-7","article-title":"Adamantinomatous craniopharyngioma as a model to understand paracrine and senescence-induced tumourigenesis","volume":"78","author":"Gonzalez-Meljem","year":"2021","journal-title":"Cell Mol Life Sci."},{"issue":"1","key":"2025062423032286600_CIT0029","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s11102-012-0418-4","article-title":"Pathology and pathogenesis of craniopharyngiomas","volume":"16","author":"Larkin","year":"2013","journal-title":"Pituitary."},{"issue":"19","key":"2025062423032286600_CIT0030","first-page":"CASE2150","article-title":"Adamantinomatous craniopharyngioma associated with a compromised blood\u2013brain barrier: patient series","volume":"1","author":"Prince","year":"2021","journal-title":"J Neurosurg Case Lessons."},{"issue":"28","key":"2025062423032286600_CIT0031","doi-asserted-by":"crossref","first-page":"11482","DOI":"10.1073\/pnas.1101553108","article-title":"Increased Wingless (Wnt) signaling in pituitary progenitor\/stem cells gives rise to pituitary tumors in mice and humans","volume":"108","author":"Gaston-Massuet","year":"2011","journal-title":"Proc Natl Acad Sci U S A."},{"issue":"2","key":"2025062423032286600_CIT0032","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/ng.2868","article-title":"Exome sequencing identifies BRAF mutations in papillary craniopharyngiomas","volume":"46","author":"Brastianos","year":"2014","journal-title":"Nat Genet."},{"issue":"1","key":"2025062423032286600_CIT0033","doi-asserted-by":"crossref","first-page":"217","DOI":"10.3171\/2018.3.JNS172528","article-title":"Clinical and biological significance of adamantinomatous craniopharyngioma with CTNNB1 mutation","volume":"131","author":"Hara","year":"2019","journal-title":"J Neurosurg."},{"issue":"11","key":"2025062423032286600_CIT0034","doi-asserted-by":"crossref","first-page":"e20191115","DOI":"10.1084\/jem.20191115","article-title":"\u03b2-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion","volume":"217","author":"Du","year":"2020","journal-title":"J Exp Med."},{"issue":"1","key":"2025062423032286600_CIT0035","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.tcb.2018.08.005","article-title":"WNT signaling in cancer immunosurveillance","volume":"29","author":"Galluzzi","year":"2019","journal-title":"Trends Cell Biol."},{"issue":"1","key":"2025062423032286600_CIT0036","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41392-021-00762-6","article-title":"Wnt\/\u03b2-catenin signalling: function, biological mechanisms, and therapeutic opportunities","volume":"7","author":"Liu","year":"2022","journal-title":"Signal Transduct Target Ther"},{"issue":"2","key":"2025062423032286600_CIT0037","first-page":"126","article-title":"Genomic alterations of adamantinomatous and papillary craniopharyngioma","volume":"76","author":"Goschzik","year":"2017","journal-title":"J Neuropathol Exp Neurol."},{"issue":"1","key":"2025062423032286600_CIT0038","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/neup.12408","article-title":"High-resolution melting and immunohistochemical analysis efficiently detects mutually exclusive genetic alterations of adamantinomatous and papillary craniopharyngiomas","volume":"38","author":"Yoshimoto","year":"2018","journal-title":"Neuropathol"},{"issue":"7","key":"2025062423032286600_CIT0039","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1055\/a-0593-5956","article-title":"Impact of the canonical Wnt pathway activation on the pathogenesis and prognosis of adamantinomatous craniopharyngiomas","volume":"50","author":"Juc\u00e1","year":"2018","journal-title":"Horm Metab Res."},{"issue":"5","key":"2025062423032286600_CIT0040","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/nan.12613","article-title":"CTNNB1 mutations are clonal in adamantinomatous craniopharyngioma","volume":"46","author":"Apps","year":"2020","journal-title":"Neuropathol Appl Neurobiol."},{"issue":"2","key":"2025062423032286600_CIT0041","first-page":"266","article-title":"The molecular pathogenesis of craniopharyngiomas","volume":"67","author":"Campanini","year":"2023","journal-title":"Arch Endocrinol Metab"},{"issue":"6","key":"2025062423032286600_CIT0042","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1007\/s00401-020-02232-9","article-title":"Familial adenomatous polyposis associated craniopharyngioma secondary to both germline and somatic mutations in the APC gene","volume":"140","author":"Passos","year":"2020","journal-title":"Acta Neuropathol."},{"key":"2025062423032286600_CIT0043","doi-asserted-by":"crossref","first-page":"1167776","DOI":"10.3389\/fendo.2023.1167776","article-title":"Correlations between the expression of molecules in the TGF-\u03b2 signaling pathway and clinical factors in adamantinomatous craniopharyngiomas","volume":"14","author":"Jin","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"4","key":"2025062423032286600_CIT0044","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/s41556-018-0062-y","article-title":"PSPC1 mediates TGF-\u03b21 autocrine signalling and Smad2\/3 target switching to promote EMT, stemness and metastasis","volume":"20","author":"Yeh","year":"2018","journal-title":"Nat Cell Biol."},{"issue":"1-2","key":"2025062423032286600_CIT0045","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000084509","article-title":"Invasion and metastasis in colorectal cancer: epithelial-mesenchymal transition, mesenchymal-epithelial transition, stem cells and \u03b2-catenin","volume":"179","author":"Brabletz","year":"2005","journal-title":"Cells Tissues Organs"},{"issue":"18","key":"2025062423032286600_CIT0046","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1158\/0008-5472.CAN-20-3941","article-title":"TGF\u03b2 signaling activated by cancer-associated fibroblasts determines the histological signature of lung adenocarcinoma","volume":"81","author":"Sato","year":"2021","journal-title":"Cancer Res."},{"key":"2025062423032286600_CIT0047","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ebiom.2019.03.018","article-title":"Simultaneous blocking of CD47 and PD-L1 increases innate and adaptive cancer immune responses and cytokine release","volume":"42","author":"Lian","year":"2019","journal-title":"EBioMed"},{"issue":"17","key":"2025062423032286600_CIT0048","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.29444","article-title":"Isolation and characterization of living circulating tumor cells in patients by immunomagnetic negative enrichment coupled with flow cytometry","volume":"121","author":"Lu","year":"2015","journal-title":"Cancer."},{"issue":"2","key":"2025062423032286600_CIT0049","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/CMR.0000000000000629","article-title":"Evolutionarily conserved resistance to phagocytosis observed in melanoma cells is insensitive to upregulation of pro-phagocytic signals and to CD47 blockade","volume":"30","author":"Anderson","year":"2020","journal-title":"Melanoma Res."},{"issue":"4","key":"2025062423032286600_CIT0050","doi-asserted-by":"crossref","first-page":"e12795","DOI":"10.1111\/nan.12795","article-title":"CD47 promotes the proliferation and migration of adamantinomatous craniopharyngioma cells by activating the MAPK\/ERK pathway, and CD47 blockade facilitates microglia-mediated phagocytosis","volume":"48","author":"Zhang","year":"2022","journal-title":"Neuropathology Appl Neurobio."},{"issue":"5","key":"2025062423032286600_CIT0051","first-page":"755","article-title":"Mutation in exon 7 of PTCH deregulates SHH\/PTCH\/SMO signaling: possible linkage to WNT","volume":"17","author":"Musani","year":"2006","journal-title":"Int J Mol Med."},{"issue":"5","key":"2025062423032286600_CIT0052","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1530\/EJE-14-0934","article-title":"Sonic Hedgehog pathway is upregulated in adamantinomatous craniopharyngiomas","volume":"172","author":"Gomes","year":"2015","journal-title":"Eur J Endocrinol."},{"issue":"18","key":"2025062423032286600_CIT0053","doi-asserted-by":"crossref","first-page":"3347","DOI":"10.1021\/acschemneuro.3c00031","article-title":"Transcription factor GLI1 induces IL-6-mediated inflammatory response and facilitates the progression of adamantinomatous craniopharyngioma","volume":"14","author":"Zhao","year":"2023","journal-title":"ACS Chem Neurosci."},{"issue":"4-5","key":"2025062423032286600_CIT0054","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1080\/14728222.2023.2218613","article-title":"Targeting the EGFR signaling pathway in cancer therapy: what\u2019s new in 2023","volume":"27","author":"Halder","year":"2023","journal-title":"Expert Opin Ther Targets."},{"issue":"6","key":"2025062423032286600_CIT0055","doi-asserted-by":"crossref","first-page":"E3","DOI":"10.3171\/2016.9.FOCUS16308","article-title":"Potential evolution of neurosurgical treatment paradigms for craniopharyngioma based on genomic and transcriptomic characteristics","volume":"41","author":"Robinson","year":"2016","journal-title":"Neurosurg Focus."},{"issue":"13","key":"2025062423032286600_CIT0056","doi-asserted-by":"crossref","first-page":"4367","DOI":"10.1158\/1078-0432.CCR-10-2811","article-title":"EGFR signaling regulates tumor cell migration in craniopharyngiomas","volume":"17","author":"H\u00f6lsken","year":"2011","journal-title":"Clin Cancer Res"},{"issue":"1","key":"2025062423032286600_CIT0057","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/bpa.12148","article-title":"Insights into the infiltrative behavior of adamantinomatous craniopharyngioma in a new xenotransplant mouse model","volume":"25","author":"Stache","year":"2015","journal-title":"Brain Pathol"},{"issue":"3","key":"2025062423032286600_CIT0058","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1002\/cncr.10281","article-title":"Angiogenesis in patients with craniopharyngiomas: correlation with treatment and outcome","volume":"94","author":"Vidal","year":"2002","journal-title":"Cancer."},{"issue":"12","key":"2025062423032286600_CIT0059","doi-asserted-by":"crossref","first-page":"2346","DOI":"10.1007\/s11064-011-0560-9","article-title":"Expression of matrix metalloproteinase-9, type IV collagen and vascular endothelial growth factor in adamantinous craniopharyngioma","volume":"36","author":"Xia","year":"2011","journal-title":"Neurochem Res."},{"key":"2025062423032286600_CIT0060","doi-asserted-by":"crossref","first-page":"995655","DOI":"10.3389\/fimmu.2022.995655","article-title":"Immune infiltration in aggressive papillary craniopharyngioma: high infiltration but low action","volume":"13","author":"Jia","year":"2022","journal-title":"Front Immunol."},{"issue":"9","key":"2025062423032286600_CIT0061","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1093\/jnen\/nlx061","article-title":"Molecular analyses reveal inflammatory mediators in the solid component and cyst fluid of human adamantinomatous craniopharyngioma","volume":"76","author":"Donson","year":"2017","journal-title":"J Neuropathol Exp Neurol."},{"key":"2025062423032286600_CIT0062","doi-asserted-by":"crossref","first-page":"791","DOI":"10.3389\/fonc.2019.00791","article-title":"Targeting IL-6 is a potential treatment for primary cystic craniopharyngioma","volume":"9","author":"Grob","year":"2019","journal-title":"Front Oncol."},{"issue":"1","key":"2025062423032286600_CIT0063","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41467-017-01992-5","article-title":"Stem cell senescence drives age-attenuated induction of pituitary tumours in mouse models of paediatric craniopharyngioma","volume":"8","author":"Gonzalez-Meljem","year":"2017","journal-title":"Nat Commun."},{"issue":"6","key":"2025062423032286600_CIT0064","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/neuonc\/noae015","article-title":"Unraveling the complexity of the senescence-associated secretory phenotype in adamantinomatous craniopharyngioma using multimodal machine learning analysis","volume":"26","author":"Prince","year":"2024","journal-title":"Neuro-Oncology."},{"issue":"1","key":"2025062423032286600_CIT0065","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13578-024-01299-1","article-title":"Single-cell and spatial sequencing identifies senescent and germinal tumor cells in adamantinomatous craniopharyngiomas","volume":"14","author":"Wang","year":"2024","journal-title":"Cell Biosci"},{"issue":"10","key":"2025062423032286600_CIT0066","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.trecan.2020.05.004","article-title":"Senescent cells in cancer therapy: friends or foes","volume":"6","author":"Wang","year":"2020","journal-title":"Trends Cancer"},{"issue":"5","key":"2025062423032286600_CIT0067","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3171\/2010.11.JNS10670","article-title":"Neurosurgical treatment of craniopharyngioma in adults and children: early and long-term results in a large case series","volume":"114","author":"Mortini","year":"2011","journal-title":"J Neurosurg."},{"key":"2025062423032286600_CIT0068","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.wneu.2022.05.038","article-title":"Quality of life in craniopharyngioma: a systematic review","volume":"164","author":"Castle-Kirszbaum","year":"2022","journal-title":"World Neurosurg"},{"issue":"1 Suppl","key":"2025062423032286600_CIT0069","first-page":"3","article-title":"Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement","volume":"106","author":"Puget","year":"2007","journal-title":"J Neurosurg."},{"issue":"6","key":"2025062423032286600_CIT0070","doi-asserted-by":"crossref","first-page":"E13","DOI":"10.3171\/2016.9.FOCUS16304","article-title":"Craniopharyngioma adherence: a comprehensive topographical categorization and outcome-related risk stratification model based on the methodical examination of 500 tumors","volume":"41","author":"Prieto","year":"2016","journal-title":"Neurosurg Focus."},{"key":"2025062423032286600_CIT0071","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/978-3-7091-1376-9_7","article-title":"What is the role of radiosurgery in the management of sellar tumors","volume":"116","author":"Hori","year":"2013","journal-title":"Acta Neurochir Suppl."},{"issue":"7","key":"2025062423032286600_CIT0072","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/B978-0-12-820683-6.00007-5","article-title":"Craniopharyngiomas primarily affecting the hypothalamus","volume":"181","author":"Pascual","year":"2021","journal-title":"Handb Clin Neurol"},{"issue":"14","key":"2025062423032286600_CIT0073","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.3390\/cancers16142532","article-title":"Topography and radiological variables as ancillary parameters for evaluating tissue adherence, hypothalamic-pituitary dysfunction, and recurrence in craniopharyngioma: an integrated multidisciplinary overview","volume":"16","author":"Calandrelli","year":"2024","journal-title":"Cancers (Basel)"},{"issue":"9-10","key":"2025062423032286600_CIT0074","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1159\/000504512","article-title":"The diagnosis and treatment of craniopharyngioma","volume":"110","author":"M\u00fcller","year":"2020","journal-title":"Neuroendocrinology."},{"key":"2025062423032286600_CIT0075","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/neurosurgery\/27.CN_suppl_1.169","article-title":"Craniopharyngiomas: transsphenoidal method of approach\u2014for the virtuoso only","volume":"27","author":"Ciric","year":"1980","journal-title":"Clin Neurosurg."},{"key":"2025062423032286600_CIT0076","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1007\/978-3-7091-8813-2_16","article-title":"Microsurgical topography of craniopharyngiomas","volume":"35","author":"Steno","year":"1985","journal-title":"Acta Neurochir Suppl (Wien)."},{"issue":"1","key":"2025062423032286600_CIT0077","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3171\/jns.1990.73.1.0003","article-title":"Total removal of craniopharyngiomas. Approaches and long-term results in 144 patients","volume":"73","author":"Ya\u015fargil","year":"1990","journal-title":"J Neurosurg."},{"issue":"Suppl 1","key":"2025062423032286600_CIT0078","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1159\/000120861","article-title":"Surgical management of craniopharyngioma","volume":"21","author":"Hoffman","year":"1994","journal-title":"Pediatr Neurosurg."},{"issue":"2","key":"2025062423032286600_CIT0079","doi-asserted-by":"crossref","first-page":"141","DOI":"10.2176\/nmc.37.141","article-title":"Surgical management of craniopharyngiomas: a review","volume":"37","author":"Samii","year":"1997","journal-title":"Neurol Med Chir (Tokyo)."},{"issue":"8","key":"2025062423032286600_CIT0080","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00701-004-0295-3","article-title":"Intraventricular craniopharyngiomas: topographical classification and surgical approach selection based on an extensive overview","volume":"146","author":"Pascual","year":"2004","journal-title":"Acta Neurochir (Wien)."},{"issue":"8-9","key":"2025062423032286600_CIT0081","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1007\/s00381-005-1203-8","article-title":"Origin of craniopharyngiomas: implication on the growth pattern","volume":"21","author":"Wang","year":"2005","journal-title":"Childs Nerv Syst."},{"issue":"4","key":"2025062423032286600_CIT0082","doi-asserted-by":"crossref","first-page":"715","DOI":"10.3171\/JNS\/2008\/108\/4\/0715","article-title":"Expanded endonasal approach, a fully endoscopic transnasal approach for the resection of midline suprasellar craniopharyngiomas: a new classification based on the infundibulum","volume":"108","author":"Kassam","year":"2008","journal-title":"J Neurosurg."},{"issue":"1","key":"2025062423032286600_CIT0083","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3171\/2019.3.JNS181953","article-title":"Clinical features and operative technique of transinfundibular craniopharyngioma","volume":"133","author":"Tang","year":"2019","journal-title":"J Neurosurg."},{"issue":"5","key":"2025062423032286600_CIT0084","first-page":"ons269","article-title":"Endonasal versus supraorbital keyhole removal of craniopharyngiomas and tuberculum sellae meningiomas","volume":"64","author":"Fatemi","year":"2009","journal-title":"Neurosurgery."},{"issue":"2-3","key":"2025062423032286600_CIT0085","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.wneu.2010.06.014","article-title":"Surgical outcome in 90 patients with craniopharyngioma: an evaluation of transsphenoidal surgery","volume":"74","author":"Yamada","year":"2010","journal-title":"World Neurosurg"},{"issue":"4","key":"2025062423032286600_CIT0086","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1007\/s00701-010-0940-y","article-title":"Anatomic relations of the arachnoidea around the pituitary stalk: relevance for surgical removal of craniopharyngiomas","volume":"153","author":"Qi","year":"2011","journal-title":"Acta Neurochir (Wien)."},{"issue":"14","key":"2025062423032286600_CIT0087","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.21037\/atm-21-2924","article-title":"Clinical impact of craniopharyngioma classification based on location origin: a multicenter retrospective study","volume":"9","author":"Hu","year":"2021","journal-title":"Ann Transl Med"},{"issue":"12","key":"2025062423032286600_CIT0088","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2176\/nmc.oa.2014-0038","article-title":"Indication and limitations of endoscopic extended transsphenoidal surgery for craniopharyngioma","volume":"54","author":"Matsuo","year":"2014","journal-title":"Neurol Med Chir (Tokyo)."},{"issue":"6","key":"2025062423032286600_CIT0089","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/2016.9.FOCUS16211","article-title":"Aggressive surgery based on an anatomical subclassification of craniopharyngiomas","volume":"41","author":"Morisako","year":"2016","journal-title":"Neurosurg Focus."},{"issue":"3","key":"2025062423032286600_CIT0090","doi-asserted-by":"crossref","first-page":"627","DOI":"10.3171\/2015.3.JNS142254","article-title":"Comparative analysis of outcomes following craniotomy and expanded endoscopic endonasal transsphenoidal resection of craniopharyngioma and related tumors: a single-institution study","volume":"124","author":"Jeswani","year":"2016","journal-title":"J Neurosurg."},{"issue":"1","key":"2025062423032286600_CIT0091","doi-asserted-by":"crossref","first-page":"10215","DOI":"10.1038\/s41598-018-28282-4","article-title":"A novel endoscopic classification for craniopharyngioma based on its origin","volume":"8","author":"Tang","year":"2018","journal-title":"Sci Rep."},{"issue":"4","key":"2025062423032286600_CIT0092","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/17446651.2020.1770081","article-title":"Craniopharyngioma treatment: an updated summary of important clinicopathological concepts","volume":"15","author":"Prieto","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2025062423032286600_CIT0093","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.wneu.2017.02.115","article-title":"Surgical outcome as related to the degree of hypothalamic involvement","volume":"104","author":"Prieto","year":"2017","journal-title":"World Neurosurg"},{"key":"2025062423032286600_CIT0094","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.wneu.2020.05.171","article-title":"Surgical anatomy applied to the resection of craniopharyngiomas: anatomic compartments and surgical classifications","volume":"142","author":"Almeida","year":"2020","journal-title":"World Neurosurg"},{"issue":"3","key":"2025062423032286600_CIT0095","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1007\/s10143-020-01370-8","article-title":"Approach selection and outcomes of craniopharyngioma resection: a single-institute study","volume":"44","author":"Lei","year":"2021","journal-title":"Neurosurg Rev."},{"issue":"10","key":"2025062423032286600_CIT0096","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.1007\/s00381-023-06143-4","article-title":"Adamantinomatous craniopharyngioma: evolution in the management","volume":"39","author":"Massimi","year":"2023","journal-title":"Childs Nerv Syst."},{"issue":"3","key":"2025062423032286600_CIT0097","doi-asserted-by":"crossref","first-page":"325","DOI":"10.3171\/2021.10.PEDS21392","article-title":"A propensity-adjusted comparison of endoscopic endonasal surgery versus transcranial microsurgery for pediatric craniopharyngioma: a single-center study","volume":"29","author":"Wu","year":"2022","journal-title":"J Neurosurg Pediatr"},{"key":"2025062423032286600_CIT0098","doi-asserted-by":"crossref","first-page":"1058329","DOI":"10.3389\/fonc.2022.1058329","article-title":"Craniopharyngioma resection by endoscopic endonasal approach versus transcranial approach: a systematic review and meta-analysis of comparative studies","volume":"12","author":"Na","year":"2022","journal-title":"Front Oncol."},{"issue":"1","key":"2025062423032286600_CIT0099","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-022-00351-z","article-title":"Hypothalamic syndrome","volume":"8","author":"M\u00fcller","year":"2022","journal-title":"Nat Rev Dis Primers."},{"issue":"10","key":"2025062423032286600_CIT0100","doi-asserted-by":"crossref","first-page":"e3820","DOI":"10.1210\/clinem\/dgab397","article-title":"Childhood-onset craniopharyngioma","volume":"106","author":"Otte","year":"2021","journal-title":"J Clin Endocrinol Metab."},{"issue":"15","key":"2025062423032286600_CIT0101","doi-asserted-by":"crossref","first-page":"eadc8933","DOI":"10.1126\/sciadv.adc8933","article-title":"Single-cell RNA sequencing highlights intratumor heterogeneity and intercellular network featured in adamantinomatous craniopharyngioma","volume":"9","author":"Jiang","year":"2023","journal-title":"Sci Adv."},{"issue":"6","key":"2025062423032286600_CIT0102","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1227\/neu.0000000000002346","article-title":"Characteristics and outcomes in pediatric versus adult craniopharyngiomas: a systematic review and meta-analysis","volume":"92","author":"Pang","year":"2023","journal-title":"Neurosurgery."},{"issue":"11","key":"2025062423032286600_CIT0103","doi-asserted-by":"crossref","first-page":"e32112","DOI":"10.1016\/j.heliyon.2024.e32112","article-title":"Craniopharyngioma: a comprehensive review of the clinical presentation, radiological findings, management, and future Perspective","volume":"10","author":"Alboqami","year":"2024","journal-title":"Heliyon"},{"key":"2025062423032286600_CIT0104","first-page":"121","article-title":"Medical therapy for craniopharyngiomas.","author":"Alexandraki","year":"2021"},{"issue":"15","key":"2025062423032286600_CIT0105","doi-asserted-by":"crossref","first-page":"8429","DOI":"10.3390\/ijms23158429","article-title":"Cancer prevention with molecular targeted therapies","volume":"23","author":"Paleari","year":"2022","journal-title":"Int J Mol Sci ."},{"issue":"2","key":"2025062423032286600_CIT0106","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00428-023-03731-2","article-title":"Molecular pathology in diagnosis and prognostication of head and neck tumors","volume":"484","author":"Sk\u00e1lov\u00e1","year":"2024","journal-title":"Virchows Arch."},{"issue":"6","key":"2025062423032286600_CIT0107","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1016\/S0002-9440(10)64477-X","article-title":"Craniopharyngiomas of adamantinomatous type harbor \u03b2-Catenin gene mutations","volume":"161","author":"Sekine","year":"2002","journal-title":"Am J Pathol."},{"issue":"2","key":"2025062423032286600_CIT0108","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1530\/EJE-21-1269","article-title":"Telomere length and Wnt\/\u03b2-catenin pathway in adamantinomatous craniopharyngiomas","volume":"187","author":"Mota","year":"2022","journal-title":"Eur J Endocrinol."},{"issue":"3","key":"2025062423032286600_CIT0109","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1111\/j.1750-3639.2008.00180.x","article-title":"Target gene activation of the Wnt signaling pathway in nuclear beta-catenin accumulating cells of adamantinomatous craniopharyngiomas","volume":"19","author":"H\u00f6lsken","year":"2009","journal-title":"Brain Pathol."},{"issue":"10","key":"2025062423032286600_CIT0110","doi-asserted-by":"crossref","first-page":"e1867","DOI":"10.1210\/clinem\/dgae006","article-title":"Epigenetic control of adamantinomatous craniopharyngiomas","volume":"109","author":"Marrero-Guti\u00e9rrez","year":"2024","journal-title":"J Clin Endocrinol Metab."},{"key":"2025062423032286600_CIT0111","doi-asserted-by":"crossref","first-page":"216905","DOI":"10.1016\/j.canlet.2024.216905","article-title":"Axl as a potential therapeutic target for adamantinomatous craniopharyngiomas: based on single nucleus RNA-seq and spatial transcriptome profiling","volume":"592","author":"Chen","year":"2024","journal-title":"Cancer Lett."},{"issue":"5","key":"2025062423032286600_CIT0112","doi-asserted-by":"crossref","first-page":"947","DOI":"10.21037\/tp-23-152","article-title":"Machine learning approach to screen new diagnostic features of adamantinomatous craniopharyngioma and explore personalised treatment strategies","volume":"12","author":"Wu","year":"2023","journal-title":"Transl Pediatr"},{"issue":"1","key":"2025062423032286600_CIT0113","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s11060-016-2273-z","article-title":"Clinical and prognostic role of annexin A2 in adamantinomatous craniopharyngioma","volume":"131","author":"Wang","year":"2017","journal-title":"J Neurooncol."},{"issue":"1","key":"2025062423032286600_CIT0114","doi-asserted-by":"crossref","first-page":"3049","DOI":"10.1038\/s41598-023-29664-z","article-title":"Molecular biological features of cyst wall of adamantinomatous craniopharyngioma","volume":"13","author":"Zhao","year":"2023","journal-title":"Sci Rep."},{"key":"2025062423032286600_CIT0115","doi-asserted-by":"crossref","first-page":"704130","DOI":"10.3389\/fneur.2021.704130","article-title":"A novel immune classification for predicting immunotherapy responsiveness in patients with adamantinomatous craniopharyngioma","volume":"12","author":"Yuan","year":"2021","journal-title":"Front Neurol."},{"issue":"5","key":"2025062423032286600_CIT0116","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.3171\/2017.1.JNS162232","article-title":"Do craniopharyngioma molecular signatures correlate with clinical characteristics","volume":"128","author":"Omay","year":"2018","journal-title":"J Neurosurg."},{"issue":"6","key":"2025062423032286600_CIT0117","doi-asserted-by":"crossref","first-page":"101188","DOI":"10.1016\/j.gendis.2023.101188","article-title":"Factor analysis and subtyping significance of CTNNB1 gene mutation detection in adamantinomatous craniopharyngioma","volume":"11","author":"Zhang","year":"2024","journal-title":"Genes Dis"},{"issue":"8","key":"2025062423032286600_CIT0118","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/neuonc\/noy035","article-title":"Multiplexed immunofluorescence reveals potential PD-1\/PD-L1 pathway vulnerabilities in craniopharyngioma","volume":"20","author":"Coy","year":"2018","journal-title":"Neuro Oncol"},{"issue":"2","key":"2025062423032286600_CIT0119","doi-asserted-by":"crossref","first-page":"e000406","DOI":"10.1136\/jitc-2019-000406","article-title":"Expression and clinical significance of PD-L1, B7-H3, B7-H4 and VISTA in craniopharyngioma","volume":"8","author":"Wang","year":"2020","journal-title":"J ImmunoTher Cancer."},{"key":"2025062423032286600_CIT0120","doi-asserted-by":"crossref","first-page":"104712","DOI":"10.1016\/j.yexmp.2021.104712","article-title":"Autophagy and immune microenvironment in craniopharyngioma and ameloblastoma","volume":"123","author":"Karpathiou","year":"2021","journal-title":"Exp Mol Pathol."},{"issue":"8","key":"2025062423032286600_CIT0121","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00381-020-04677-5","article-title":"Adamantinomatous craniopharyngioma in the molecular age and the potential of targeted therapies: a review","volume":"36","author":"Whelan","year":"2020","journal-title":"Childs Nerv Syst."},{"issue":"1","key":"2025062423032286600_CIT0122","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s40478-020-00939-0","article-title":"Transcriptional analyses of adult and pediatric adamantinomatous craniopharyngioma reveals similar expression signatures regarding potential therapeutic targets","volume":"8","author":"Prince","year":"2020","journal-title":"Acta Neuropathol Commun"},{"issue":"7","key":"2025062423032286600_CIT0123","doi-asserted-by":"crossref","first-page":"1962","DOI":"10.1016\/j.cell.2020.10.044","article-title":"Integrated proteogenomic characterization across major histological types of pediatric brain cancer","volume":"183","author":"Petralia","year":"2020","journal-title":"Cell."},{"issue":"3","key":"2025062423032286600_CIT0124","doi-asserted-by":"crossref","first-page":"e28753","DOI":"10.1002\/pbc.28753","article-title":"Radiologic response to MEK inhibition in a patient with a WNT-activated craniopharyngioma","volume":"68","author":"Patel","year":"2021","journal-title":"Pediatr Blood Cancer."},{"issue":"3","key":"2025062423032286600_CIT0125","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1111\/bpa.12502","article-title":"Proteomics in pediatric cystic craniopharyngioma","volume":"27","author":"Massimi","year":"2017","journal-title":"Brain Pathol."},{"issue":"2","key":"2025062423032286600_CIT0126","doi-asserted-by":"crossref","first-page":"723","DOI":"10.3390\/ijms25020723","article-title":"Advancing craniopharyngioma management: a systematic review of current targeted therapies and future perspectives","volume":"25","author":"Agosti","year":"2024","journal-title":"Int J Mol Sci ."},{"issue":"1","key":"2025062423032286600_CIT0127","doi-asserted-by":"crossref","first-page":"E7","DOI":"10.3171\/2019.10.FOCUS19705","article-title":"Adamantinomatous craniopharyngioma: moving toward targeted therapies","volume":"48","author":"Hengartner","year":"2020","journal-title":"Neurosurg Focus."},{"issue":"2","key":"2025062423032286600_CIT0128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.3171\/jns.2000.92.2.0255","article-title":"Phase II evaluation of interferon \u03b1-2a for progressive or recurrent craniopharyngiomas","volume":"92","author":"Jakacki","year":"2000","journal-title":"J Neurosurg."},{"issue":"6","key":"2025062423032286600_CIT0129","doi-asserted-by":"crossref","first-page":"498","DOI":"10.3171\/2012.9.PEDS12225","article-title":"Pegylated interferon-\u03b1-2b for children with recurrent craniopharyngioma","volume":"10","author":"Yeung","year":"2012","journal-title":"J Neurosurg Pediatr"},{"issue":"10","key":"2025062423032286600_CIT0130","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1093\/neuonc\/nox056","article-title":"Intracystic interferon-alpha in pediatric craniopharyngioma patients: an international multicenter assessment on behalf of SIOPE and ISPN","volume":"19","author":"Kilday","year":"2017","journal-title":"Neuro Oncol"},{"issue":"11","key":"2025062423032286600_CIT0131","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1093\/neuonc\/noaa119","article-title":"Phase II study of peginterferon alpha-2b for patients with unresectable or recurrent craniopharyngiomas: a pediatric brain tumor consortium report","volume":"22","author":"Goldman","year":"2020","journal-title":"Neuro Oncol"},{"key":"2025062423032286600_CIT0132","doi-asserted-by":"crossref","first-page":"1225734","DOI":"10.3389\/fendo.2023.1225734","article-title":"Tocilizumab for the fifth progression of cystic childhood craniopharyngioma\u2014a case report","volume":"14","author":"De Vos-Kerkhof","year":"2023","journal-title":"Front Endocrinol"},{"key":"2025062423032286600_CIT0133","author":"ClinicalTrials.gov","year":"."},{"issue":"6","key":"2025062423032286600_CIT0134","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.ando.2023.10.003","article-title":"First evidence of anti-VEGF efficacy in an adult case of adamantinomatous craniopharyngioma: case report and illustrative review","volume":"84","author":"De Rosa","year":"2023","journal-title":"Ann Endocrinol (Paris)."},{"key":"2025062423032286600_CIT0135","author":"ClinicalTrials.gov","year":"."},{"key":"2025062423032286600_CIT0136","author":"ClinicalTrials.gov","year":"."},{"key":"2025062423032286600_CIT0137","doi-asserted-by":"crossref","first-page":"599888","DOI":"10.3389\/fonc.2020.599888","article-title":"Non-invasive radiomics approach predict invasiveness of adamantinomatous craniopharyngioma before surgery","volume":"10","author":"Ma","year":"2020","journal-title":"Front Oncol."},{"issue":"1","key":"2025062423032286600_CIT0138","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41568-022-00529-3","article-title":"The coming decade in precision oncology: six riddles","volume":"23","author":"Wahida","year":"2023","journal-title":"Nat Rev Cancer."}],"container-title":["Neuro-Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/advance-article-pdf\/doi\/10.1093\/neuonc\/noaf030\/61739895\/noaf030.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/5\/1180\/61739895\/noaf030.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article-pdf\/27\/5\/1180\/61739895\/noaf030.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,24]],"date-time":"2025-06-24T23:03:45Z","timestamp":1750806225000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/neuro-oncology\/article\/27\/5\/1180\/7997205"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,3]]},"references-count":138,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,2,3]]},"published-print":{"date-parts":[[2025,6,21]]}},"URL":"https:\/\/doi.org\/10.1093\/neuonc\/noaf030","relation":{},"ISSN":["1522-8517","1523-5866"],"issn-type":[{"value":"1522-8517","type":"print"},{"value":"1523-5866","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,5]]},"published":{"date-parts":[[2025,2,3]]}}}